Vongphanit J, Mitchell P, Wang JJ. Prevalence and progression of myopic retinopathy in an older population. Ophthalmology. 2002;109(4):704–11.
Wong YL, Saw SM. Epidemiology of pathologic myopia in asia and worldwide. Asia Pac J Ophthalmol (Phila). 2016;5(6):394–402.
Wong TY, Ferreira A, Hughes R, Carter G, Mitchell P. Epidemiology and disease burden of pathologic myopia and myopic choroidal neovascularization: an evidence-based systematic review. Am J Ophthalmol. 2014;157(1):9–25.e12.
Hayashi K, Ohno-Matsui K, Shimada N, Moriyama M, Kojima A, Hayashi W, et al. Long-term pattern of progression of myopic maculopathy: a natural history study. Ophthalmology. 2010;117(8):1595–611, 1611.e1–4.
Cohen SY, Laroche A, Leguen Y, Soubrane G, Coscas GJ. Etiology of choroidal neovascularization in young patients. Ophthalmology. 1996;103(8):1241–4.
Article CAS PubMed Google Scholar
Ohno-Matsui K, Ikuno Y, Lai TYY, Gemmy Cheung CM. Diagnosis and treatment guideline for myopic choroidal neovascularization due to pathologic myopia. Prog Retin Eye Res. 2018;63:92–106.
Ruiz-Moreno JM, Montero JA, Araiz J, Arias L, Garcia-Layana A, Carneiro A, et al. Intravitreal anti-vascular endothelial growth factor therapy for choroidal neovascularization secondary to pathologic myopia: six years outcome. Retina. 2015;35(12):2450–6.
Article CAS PubMed Google Scholar
Ruiz-Medrano J, Almazan-Alonso E, Flores-Moreno I, Puertas M, García-Zamora M, Ruiz-Moreno JM. Relationship between myopic choroidal neovascularization activity and perforating scleral vessels in high myopia. Retina. 2022;42(1):204–9.
Article CAS PubMed Central PubMed Google Scholar
Cohen SY, Oubraham H, Uzzan J, Dubois L, Tadayoni R. Causes of unsuccessful ranibizumab treatment in exudative age-related macular degeneration in clinical settings. Retina. 2012;32(8):1480–5.
Article CAS PubMed Google Scholar
Daniel E, Toth CA, Grunwald JE, Jaffe GJ, Martin DF, Fine SL, et al. Risk of scar in the comparison of age-related macular degeneration treatments trials. Ophthalmology. 2014;121(3):656–66.
Ahn SJ, Park KH, Woo SJ. Subretinal fibrosis after antivascular endothelial growth factor therapy in eyes with myopic choroidal neovascularization. Retina. 2016;36(11):2140–9.
Article CAS PubMed Google Scholar
Xiao H, Zhao X, Li S, Sun L, Xin W, Wang Z, et al. Risk factors for subretinal fibrosis after anti-VEGF treatment of myopic choroidal neovascularisation. Br J Ophthalmol. 2021;105(1):103–8.
Xie S, Du R, Fang Y, Onishi Y, Igarashi T, Takahashi H, et al. Dilated choroidal veins and their role in recurrences of myopic macular neovascularisations. Br J Ophthalmol. 2022;106(10):1429–35.
Li S, Ding X, Zhang J, Lu L. Two different initial treatment regimens of ranibizumab in myopic choroidal neovascularization: 12-month results from a randomized controlled study-Response. Clin Exp Ophthalmol. 2019;47(5):685–6.
Article CAS PubMed Google Scholar
Ding X, Li J, Zeng J, Ma W, Liu R, Li T, et al. Choroidal thickness in healthy Chinese subjects. Invest Ophthalmol Vis Sci. 2011;52(13):9555–60.
Cheong KX, Cheung CMG, Teo KYC. Review of fibrosis in neovascular age-related macular degeneration. Am J Ophthalmol. 2023;246:192–222.
Article CAS PubMed Google Scholar
Xie S, Fang Y, Du R, Onishi Y, Yokoi T, Moriyama M, et al. Role of dilated subfoveal choroidal veins in eyes with myopic macular neovascularization. Retina. 2021;41(5):1063–70.
Article CAS PubMed Google Scholar
Wolf S, Balciuniene VJ, Laganovska G, Menchini U, Ohno-Matsui K, Sharma T, et al. RADIANCE: a randomized controlled study of ranibizumab in patients with choroidal neovascularization secondary to pathologic myopia. Ophthalmology. 2014;121(3):682–92.e2.
Rofagha S, Bhisitkul RB, Boyer DS, Sadda SR, Zhang K, SEVEN-UP Study Group. Seven-year outcomes in ranibizumab-treated patients in ANCHOR, MARINA, and HORIZON: a multicenter cohort study (SEVEN-UP). Ophthalmology. 2013;120(11):2292–9.
Ohno-Matsui K. Proposed classification of posterior staphylomas based on analyses of eye shape by three-dimensional magnetic resonance imaging and wide-field fundus imaging. Ophthalmology. 2014;121(9):1798–809.
Matsumoto H, Kishi S, Mukai R, Akiyama H. Remodeling of macular vortex veins in pachychoroid neovasculopathy. Sci Rep. 2019;9(1):14689.
Article PubMed Central PubMed Google Scholar
Ohno-Matsui K, Akiba M, Modegi T, Tomita M, Ishibashi T, Tokoro T, et al. Association between shape of sclera and myopic retinochoroidal lesions in patients with pathologic myopia. Invest Ophthalmol Vis Sci. 2012;53(10):6046–61.
Hung JH, Yang CM, Yang CH, Ho TC, Lai TT, Hsieh YT. Dilated choroidal vascular channels in pachychoroid neovasculopathy. Clin Exp Ophthalmol. 2023;51(1):44–57.
Ohkuma H, Ryan SJ. Vascular casts of experimental subretinal neovascularization in monkeys. Invest Ophthalmol Vis Sci. 1983;24(4):481–90.
Ohno-Matsui K, Akiba M, Ishibashi T, Moriyama M. Observations of vascular structures within and posterior to sclera in eyes with pathologic myopia by swept-source optical coherence tomography. Invest Ophthalmol Vis Sci. 2012;53(11):7290–8.
Moriyama M, Ohno-Matsui K, Futagami S, Yoshida T, Hayashi K, Shimada N, et al. Morphology and long-term changes of choroidal vascular structure in highly myopic eyes with and without posterior staphyloma. Ophthalmology. 2007;114(9):1755–62.
Pedinielli A, Souied EH, Perrenoud F, Leveziel N, Caillaux V, Querques G. In vivo visualization of perforating vessels and focal scleral ectasia in pathological myopia. Invest Ophthalmol Vis Sci. 2013;54(12):7637–43.
Bloch SB, Lund-Andersen H, Sander B, Larsen M. Subfoveal fibrosis in eyes with neovascular age-related macular degeneration treated with intravitreal ranibizumab. Am J Ophthalmol. 2013;156(1):116–24.e1.
Comments (0)